RZTBBVRYWOBHRF-UHFFFAOYSA-N
C35H46F3N3O4 — CID 135760613
Data last refreshed: (MolForge compound catalog, from PubChem)
About RZTBBVRYWOBHRF-UHFFFAOYSA-N
RZTBBVRYWOBHRF-UHFFFAOYSA-N (PubChem CID 135760613) has the molecular formula C35H46F3N3O4 and a molecular weight of 629.76 g/mol. Its IUPAC name is 4-[[2-nitro-4-(trifluoromethyl)phenyl]diazenyl]-2-octadecoxynaphthalen-1-ol.
Molecular Properties
| Compound Name | RZTBBVRYWOBHRF-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 135760613 |
| Molecular Formula | C35H46F3N3O4 |
| Molecular Weight | 629.76 g/mol |
| Exact Mass | 629.34 |
| IUPAC Name | 4-[[2-nitro-4-(trifluoromethyl)phenyl]diazenyl]-2-octadecoxynaphthalen-1-ol |
| SMILES | CCCCCCCCCCCCCCCCCCOc1cc(/N=N/c2ccc(C(F)(F)F)cc2[N+](=O)[O-])c2ccccc2c1O |
| InChI | InChI=1S/C35H46F3N3O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-24-45-33-26-31(28-20-17-18-21-29(28)34(33)42)40-39-30-23-22-27(35(36,37)38)25-32(30)41(43)44/h17-18,20-23,25-26,42H,2-16,19,24H2,1H3/b40-39+ |
| InChIKey | RZTBBVRYWOBHRF-XQQUEIPISA-N |
| XLogP | 12.53 |
| TPSA | 97.32 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 629.76 |
| LogP ≤ 5 | 12.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135760613 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.